These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16956827)

  • 1. DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma.
    Voso MT; Gumiero D; D'Alo' F; Guidi F; Mansueto G; Di Febo AL; Massini G; Martini M; Larocca LM; Hohaus S; Leone G
    Haematologica; 2006 Sep; 91(9):1252-6. PubMed ID: 16956827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent death-associated protein kinase promoter hypermethylation in multiple myeloma.
    Ng MH; To KW; Lo KW; Chan S; Tsang KS; Cheng SH; Ng HK
    Clin Cancer Res; 2001 Jun; 7(6):1724-9. PubMed ID: 11410512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of death-associated protein-kinase expression in hepatocellular carcinomas.
    Matsumoto H; Nagao M; Ogawa S; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Fujii H; Koyama F; Mukogawa T; Nakajima Y
    Anticancer Res; 2003; 23(2B):1333-41. PubMed ID: 12820391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients.
    Wong TS; Chang HW; Tang KC; Wei WI; Kwong DL; Sham JS; Yuen AP; Kwong YL
    Clin Cancer Res; 2002 Feb; 8(2):433-7. PubMed ID: 11839660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation-mediated partial transcriptional silencing of DAP-kinase gene in bladder cancer.
    Sobti RC; MalekZadeh K; Nikbakht M; Sadeghi IA; Shekari M; Singh SK
    Biomarkers; 2010 Mar; 15(2):167-74. PubMed ID: 19958159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
    Shiramizu B; Mick P
    Med Pediatr Oncol; 2003 Dec; 41(6):527-31. PubMed ID: 14595709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation of Death-associated protein-kinase gene associated with advance stage gastric cancer.
    Chan AW; Chan MW; Lee TL; Ng EK; Leung WK; Lau JY; Tong JH; Chan FK; To KF
    Oncol Rep; 2005 May; 13(5):937-41. PubMed ID: 15809761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent death-associated protein-kinase promoter hypermethylation in brain metastases of solid tumors.
    Gonzalez-Gomez P; Bello MJ; Alonso ME; Lomas J; Arjona D; Amiñoso C; De Campos JM; Isla A; Gutierrez M; Rey JA
    Oncol Rep; 2003; 10(4):1031-3. PubMed ID: 12792765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
    Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K
    Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review.
    Hayslip J; Montero A
    Mol Cancer; 2006 Oct; 5():44. PubMed ID: 17026765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker.
    Giachelia M; Bozzoli V; D'Alò F; Tisi MC; Massini G; Maiolo E; Guidi F; Cupelli E; Martini M; Larocca LM; Voso MT; Leone G; Hohaus S
    J Mol Diagn; 2014 Jul; 16(4):467-76. PubMed ID: 24814955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.
    Hoffmann AC; Kaifi JT; Vallböhmer D; Yekebas E; Grimminger P; Leers JM; Izbicki JR; Hölscher AH; Schneider PM; Metzger R; Brabender J
    J Surg Oncol; 2009 Oct; 100(5):414-7. PubMed ID: 19653236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage I/II follicular lymphoma: spread of bcl-2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy.
    Pulsoni A; Starza ID; Frattarelli N; Ghia E; Carlotti E; Cavalieri E; Matturro A; Tempera S; Rambaldi A; Foà R
    Br J Haematol; 2007 May; 137(3):216-20. PubMed ID: 17408460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
    Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
    Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase.
    Chen WT; Hung WC; Kang WY; Huang YC; Chai CY
    Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma.
    Chim CS; Liang R; Fung TK; Choi CL; Kwong YL
    J Clin Pathol; 2007 Jun; 60(6):664-9. PubMed ID: 17557868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.